Quebec Adds Momentum To Canadian Biosimilar Switching
Canadian Province Becomes Latest To Introduce Switching Program
Quebec has become the latest Canadian province to introduce a biosimilar switching program, following in the footsteps of British Columbia, Alberta and New Brunswick.
You may also be interested in...
New Brunswick has become the latest Canadian province to introduce a biosimilar switching program, with the newly-introduced scheme covering several biologic molecules.
A dedicated website will spearhead a public education campaign initiated by Sandoz Canada for biosimilars, as their influence and presence continue to grow in the North American market. Sandoz itself is planning a portfolio of five products by the middle of 2021.
As part of its update to a fact sheet on biologics and biosimilars, Health Canada has clarified its position on biosimilar switching.